Treatment of B-cell depleted COVID-19 patients with convalescent plasma and plasma-based products

Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults

(2021) Romina Libster et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis

(2020) Niveditha Devasenapathy et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Deployment of convalescent plasma for the prevention and treatment of COVID-19

(2020) Evan M. Bloch et al.   JOURNAL OF CLINICAL INVESTIGATION

Convalescent plasma a clutch at straws in COVID‐19 management! A systematic review and meta‐analysis

(2020) Soumya Sarkar et al.   JOURNAL OF MEDICAL VIROLOGY

COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?

(2020) Giovanni Novi et al.   Multiple Sclerosis and Related Disorders

Convalescent plasma therapy for B-cell depleted patients with protracted COVID-19 disease

(2020) Thomas Hueso et al.   BLOOD

Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After Rituximab

(2020) Igor Kos et al.   Frontiers in Oncology

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host

(2020) Bina Choi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection

(2011) I. F. Hung et al.   CLINICAL INFECTIOUS DISEASES

The role of B lymphocytes as antigen-presenting cells

(2008) Xinjian Chen et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS